Cargando…
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173290/ https://www.ncbi.nlm.nih.gov/pubmed/34078654 http://dx.doi.org/10.1136/jitc-2020-002029 |
| _version_ | 1783702696800288768 |
|---|---|
| author | Wang, Jiachen Shang, Zhen Wang, Jue Xu, Jinhuan Li, Weigang Guan, Yuqi Yang, Li Zhang, Wei Shen, Kefeng Zhang, Meilan Wang, Jin Chen, Liting Li, Qinlu He, Cheng Wang, Na Huang, Liang Xiao, Yi Xiao, Min Zhou, Jianfeng |
| author_facet | Wang, Jiachen Shang, Zhen Wang, Jue Xu, Jinhuan Li, Weigang Guan, Yuqi Yang, Li Zhang, Wei Shen, Kefeng Zhang, Meilan Wang, Jin Chen, Liting Li, Qinlu He, Cheng Wang, Na Huang, Liang Xiao, Yi Xiao, Min Zhou, Jianfeng |
| author_sort | Wang, Jiachen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8173290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81732902021-06-17 MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy Wang, Jiachen Shang, Zhen Wang, Jue Xu, Jinhuan Li, Weigang Guan, Yuqi Yang, Li Zhang, Wei Shen, Kefeng Zhang, Meilan Wang, Jin Chen, Liting Li, Qinlu He, Cheng Wang, Na Huang, Liang Xiao, Yi Xiao, Min Zhou, Jianfeng J Immunother Cancer Case Report BMJ Publishing Group 2021-06-01 /pmc/articles/PMC8173290/ /pubmed/34078654 http://dx.doi.org/10.1136/jitc-2020-002029 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Case Report Wang, Jiachen Shang, Zhen Wang, Jue Xu, Jinhuan Li, Weigang Guan, Yuqi Yang, Li Zhang, Wei Shen, Kefeng Zhang, Meilan Wang, Jin Chen, Liting Li, Qinlu He, Cheng Wang, Na Huang, Liang Xiao, Yi Xiao, Min Zhou, Jianfeng MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_full | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_fullStr | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_full_unstemmed | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_short | MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy |
| title_sort | myc/bcl2/bcl6 triple hit and tp53 deletion in a case of high-grade b cell lymphoma receiving car t cell immunotherapy |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173290/ https://www.ncbi.nlm.nih.gov/pubmed/34078654 http://dx.doi.org/10.1136/jitc-2020-002029 |
| work_keys_str_mv | AT wangjiachen mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT shangzhen mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT wangjue mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT xujinhuan mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT liweigang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT guanyuqi mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT yangli mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT zhangwei mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT shenkefeng mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT zhangmeilan mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT wangjin mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT chenliting mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT liqinlu mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT hecheng mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT wangna mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT huangliang mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT xiaoyi mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT xiaomin mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy AT zhoujianfeng mycbcl2bcl6triplehitandtp53deletioninacaseofhighgradebcelllymphomareceivingcartcellimmunotherapy |